Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox

dc.contributor.authorFaúndez Cáceres, Mario
dc.contributor.authorLopez-Munoz, Rodrigo
dc.contributor.authorTorres, Gloria
dc.contributor.authorMorello, Antonio
dc.contributor.authorFerreira, Jorge
dc.contributor.authorKemmerling, Ulrike
dc.contributor.authorOrellana, Myriam
dc.contributor.authorMaya, Juan D.
dc.date.accessioned2021-03-29T12:37:34Z
dc.date.available2021-03-29T12:37:34Z
dc.date.issued2008
dc.fuente.origenBibliotecas UC
dc.identifier.doi10.1128/AAC.01454-07
dc.identifier.issn0066-4804
dc.identifier.scopusid2-s2.0-42949119652
dc.identifier.urihttps://doi.org/10.1128/AAC.01454-07
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/52921
dc.identifier.wosidWOS:000255422000035
dc.issue.numeroNo. 5
dc.language.isoen
dc.pagina.final1839
dc.pagina.inicio1837
dc.revistaANTIMICROBIAL AGENTS AND CHEMOTHERAPYes_ES
dc.rightsacceso abierto
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleButhionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimoxes_ES
dc.typeartículo
dc.volumenVol. 52
sipa.codpersvinculados174901
Files